“Bispecific T-Cell Engager Therapy in Relapsed Acute Lymphoblastic Leukemia: A Review of Published Cohorts”, ALR, vol. 7, no. 1, pp. 13–18, Aug. 2026, doi: 10.5281/zenodo.22247744.